Literature DB >> 8634422

Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I.

H Tamary1, H Shalev, D Luria, D Shaft, M Zoldan, L Shalmon, A Gruinspan, B Stark, M Chaison, E Shinar, P Resnitzky, R Zaizov.   

Abstract

Congenital dyserythropoietic anemia (CDA) type I is a rare macrocytic anemia of unknown etiology. In the present study, we redefined the clinical and laboratory picture of CDA type I, some of its pathogenic aspects, and the association with thalassemia-like features in 20 patients, all of whom belong to one Bedouin tribal group and are probably descended from a common ancestor. In each case ultrastructural studies of bone marrow (BM) erythroblasts showed the classic morphological findings of CDA type I. Serological tests for CDA type II were negative. The clinical picture was variable, but mostly benign. Some patients displayed elevated hemoglobin A2 levels or high ratio of alpha- to non-alpha- globin. However, neither family studies nor complete sequence analysis of the beta-globin was compatible with beta-thalassemia. Increased erythropoiesis was manifested by a high number of BM erythroid burst-forming units. Serum erythropoietin was also elevated. BM flow cytometry studies demonstrated arrest of erythroid precursors in the S phase of the cell cycle. The ultrastructural morphological features of the erythroid precursors, showing peripheral chromatin condensation, suggest apoptosis. Additional studies are indicated to define the molecular basis of this disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634422

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Close to unraveling the secrets of congenital dyserythropoietic anemia types I and II.

Authors:  Achille Iolascon; Jean Delaunay
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

2.  Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome 15q15.1-15.3.

Authors:  H Tamary; L Shalmon; H Shalev; A Halil; D Dobrushin; N Ashkenazi; M Zoldan; P Resnitzky; M Korostishevsky; B Bonne-Tamir; R Zaizov
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

3.  New Codanin-1 Gene Mutations in a Italian Patient with Congenital Dyserythropoietic Anemia Type I and Heterozygous Beta-Thalassemia.

Authors:  Elena D'Alcamo; V Agrigento; L Pitrolo; S Sclafani; R Barone; G Calvaruso; V Buffa; A Maggio
Journal:  Indian J Hematol Blood Transfus       Date:  2016-01-05       Impact factor: 0.900

4.  Codanin-1 mutations engineered in human erythroid cells demonstrate role of CDAN1 in terminal erythroid maturation.

Authors:  Zachary C Murphy; Michael R Getman; Jaquelyn A Myers; Kimberly N Burgos Villar; Emily Leshen; Ryo Kurita; Yukio Nakamura; Laurie A Steiner
Journal:  Exp Hematol       Date:  2020-10-16       Impact factor: 3.084

5.  TET2 plays an essential role in erythropoiesis by regulating lineage-specific genes via DNA oxidative demethylation in a zebrafish model.

Authors:  Liang Ge; Rui-peng Zhang; Feng Wan; Dong-yang Guo; Ping Wang; Li-xin Xiang; Jian-zhong Shao
Journal:  Mol Cell Biol       Date:  2014-01-06       Impact factor: 4.272

6.  Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1.

Authors:  Orly Dgany; Nili Avidan; Jean Delaunay; Tatyana Krasnov; Lea Shalmon; Hanna Shalev; Tal Eidelitz-Markus; Joseph Kapelushnik; Daniel Cattan; Alexandre Pariente; Michel Tulliez; Aurore Crétien; Pierre-Olivier Schischmanoff; Achille Iolascon; Eithan Fibach; Ariel Koren; Jochen Rössler; Martine Le Merrer; Isaac Yaniv; Rina Zaizov; Edna Ben-Asher; Tsvyia Olender; Doron Lancet; Jacques S Beckmann; Hannah Tamary
Journal:  Am J Hum Genet       Date:  2002-11-14       Impact factor: 11.025

7.  Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.

Authors:  Hannah Tamary; Hanna Shalev; Galit Perez-Avraham; Meira Zoldan; Itai Levi; Dorine W Swinkels; Toshihiko Tanno; Jeffery L Miller
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

8.  Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.

Authors:  Sharon Noy-Lotan; Orly Dgany; Roxane Lahmi; Nathaly Marcoux; Tanya Krasnov; Nissan Yissachar; Doron Ginsberg; Benny Motro; Peretz Resnitzky; Isaac Yaniv; Gary M Kupfer; Hannah Tamary
Journal:  Haematologica       Date:  2009-03-31       Impact factor: 9.941

9.  Codanin-1, mutated in the anaemic disease CDAI, regulates Asf1 function in S-phase histone supply.

Authors:  Katrine Ask; Zuzana Jasencakova; Patrice Menard; Yunpeng Feng; Geneviève Almouzni; Anja Groth
Journal:  EMBO J       Date:  2012-03-09       Impact factor: 11.598

10.  Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.

Authors:  Christian Babbs; Nigel A Roberts; Luis Sanchez-Pulido; Simon J McGowan; Momin R Ahmed; Jill M Brown; Mohamed A Sabry; David R Bentley; Gil A McVean; Peter Donnelly; Opher Gileadi; Chris P Ponting; Douglas R Higgs; Veronica J Buckle
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.